AIDS drug scandal in South Africa continuesBMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7134.797f (Published 14 March 1998) Cite this as: BMJ 1998;316:797
- Pat Sidley
The controversy surrounding attempts by a South African research team to market a cheap but untested drug against HIV infection has taken yet another twist and now involves the country's deputy president, Thabo Mbeki, as well as its health minister, Dr Nkosazana Zuma.
Both politicians have taken a high profile stance in favour of getting the drug—which has been condemned by South Africa's drug regulatory authorities—on to the market as quickly as possible. Now they have been accused by opposition parties of trying to acquire a stake in the company that owns the patent of the drug known as Virodene.
In 1997 press reports were published about a miracle cheap cure which …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial